α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
Authors
Keywords
-
Journal
NEUROLOGY
Volume 99, Issue 5, Pages 195-205
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-06-04
DOI
10.1212/wnl.0000000000200878
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
- (2022) Lorenzo Barba et al. MOVEMENT DISORDERS
- Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
- (2022) Jacob I. Ayers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnostic Value of Salivary Real‐Time Quaking‐Induced Conversion in Parkinson's Disease and Multiple System Atrophy
- (2022) Mingyue Luan et al. MOVEMENT DISORDERS
- Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
- (2021) Alex Iranzo et al. LANCET NEUROLOGY
- Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder
- (2021) Ambra Stefani et al. BRAIN
- RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease
- (2021) Angela Mammana et al. MOVEMENT DISORDERS
- In Vivo Diagnosis of Synucleinopathies
- (2021) Vincenzo Donadio et al. NEUROLOGY
- Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
- (2021) Connor Bargar et al. Acta Neuropathologica Communications
- Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies
- (2021) Marcello Rossi et al. NEUROLOGY
- Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
- (2021) Ilaria Poggiolini et al. BRAIN
- Neuropathology and molecular diagnosis of Synucleinopathies
- (2021) Shunsuke Koga et al. Molecular Neurodegeneration
- Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
- (2021) Connor Bargar et al. Molecular Neurodegeneration
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
- (2021) Marco J. Russo et al. Acta Neuropathologica Communications
- Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
- (2021) Kathrin Brockmann et al. Acta Neuropathologica Communications
- Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
- (2021) Corinne Quadalti et al. npj Parkinsons Disease
- Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study
- (2021) Anastasia Kuzkina et al. npj Parkinsons Disease
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
- (2020) Mohammad Shahnawaz et al. NATURE
- Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing
- (2020) Lorenzo Brozzetti et al. Frontiers in Neuroscience
- PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease
- (2020) Giorgio Giaccone et al. Biomolecules
- Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
- (2020) Marcello Rossi et al. ACTA NEUROPATHOLOGICA
- The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies
- (2020) Anke Van der Perren et al. ACTA NEUROPATHOLOGICA
- Structures of α-synuclein filaments from multiple system atrophy
- (2020) Manuel Schweighauser et al. NATURE
- Proteopathic Seed Amplification Assays for Neurodegenerative Disorders
- (2020) Natália do Carmo Ferreira et al. CLINICS IN LABORATORY MEDICINE
- Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue from Parkinson's Disease Patients
- (2020) Sireesha Manne et al. MOVEMENT DISORDERS
- Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
- (2020) Zerui Wang et al. JAMA Neurology
- CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
- (2020) Lorenzo Gaetani et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy
- (2020) Christina D. Orrù et al. Annals of Clinical and Translational Neurology
- A/T/(N) Profile in Cerebrospinal Fluid of Parkinson’s Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
- (2020) Giovanni Bellomo et al. Diagnostics
- Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
- (2019) Un Jung Kang et al. MOVEMENT DISORDERS
- α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
- (2019) Anouke van Rumund et al. ANNALS OF NEUROLOGY
- α ‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK 2‐linked Parkinson's disease
- (2019) Alicia Garrido et al. Annals of Clinical and Translational Neurology
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
- (2019) Chiara Maria Giulia De Luca et al. Translational Neurodegeneration
- α‐Synuclein real‐time quaking‐induced conversion in the submandibular glands of Parkinson's disease patients
- (2019) Sireesha Manne et al. MOVEMENT DISORDERS
- The vicious cycle between α ‐synuclein aggregation and autophagic‐lysosomal dysfunction
- (2019) Giovanni Bellomo et al. MOVEMENT DISORDERS
- α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
- (2019) Matilde Bongianni et al. Annals of Clinical and Translational Neurology
- Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
- (2019) Timo Strohäker et al. Nature Communications
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The invasin D protein fromYersinia pseudotuberculosisselectively binds the Fab region of host antibodies and affects colonization of the intestine
- (2018) Pooja Sadana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance
- (2018) Peter Hermann et al. NEUROLOGY
- Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
- (2018) Bradley R. Groveman et al. Acta Neuropathologica Communications
- Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
- (2018) Claudio Soto et al. NATURE NEUROSCIENCE
- Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
- (2017) Seyed-Mohammad Fereshtehnejad et al. MOVEMENT DISORDERS
- Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff
- (2017) Heiko Braak et al. Journal of Parkinsons Disease
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials
- (2015) R. B. Postuma et al. NEUROLOGY
- Editorial. Can big data bridge the chasm? Issues, opportunities, and strategies for the evolving value-based health care environment
- (2015) Christopher M. Holland et al. Neurosurgical Focus
- Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease
- (2015) Lorraine V. Kalia et al. JAMA Neurology
- Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients
- (2014) Alex Iranzo et al. PLoS One
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More